05th week of 2022 patent applcation highlights part 31 |
Patent application number | Title | Published |
20220033762 | Penicillium oxalicum SDF-25 strain and application thereof | 2022-02-03 |
20220033763 | METHOD FOR PRODUCING YEAST CONTAINING RICH-TASTE-IMPARTING SUBSTANCE AND METHOD FOR PRODUCING YEAST EXTRACT CONTAINING RICH-TASTE-IMPARTING SUBSTANCE | 2022-02-03 |
20220033764 | ENGINEERED MICROORGANISMS AND METHODS OF MAKING AND USING SAME | 2022-02-03 |
20220033765 | STORAGE STABILIZER FOR EXTRACELLULAR VESICLE AND STORAGE STABILIZATION METHOD FOR EXTRACELLULAR VESICLE | 2022-02-03 |
20220033766 | ANTIGEN-SPECIFIC T LYMPHOCYTES AND METHODS OF MAKING AND USING THE SAME | 2022-02-03 |
20220033767 | ARMORED CELLS | 2022-02-03 |
20220033768 | LIVING MAMMALIAN CELLS MODIFIED WITH FUNCTIONAL MODULAR NANOPARTICLES | 2022-02-03 |
20220033769 | Bioreactor System | 2022-02-03 |
20220033770 | MACS-BASED PURIFICATION OF STEM CELL-DERIVED RETINAL PIGMENT EPITHELIUM | 2022-02-03 |
20220033771 | Combination Treatment Of Induced Pluripotent Stem Cells Using Interleukins | 2022-02-03 |
20220033772 | FACTOR RICH PRODUCTS FROM UMBILICAL CORD MESENCHYMAL STEM CELLS | 2022-02-03 |
20220033773 | DERIVATION OF HUMAN MICROGLIA FROM PLURIPOTENT STEM CELLS | 2022-02-03 |
20220033774 | COMPOSITIONS AND METHODS FOR CYTOTOXIC CD4+ T CELLS | 2022-02-03 |
20220033775 | EXPANSION OF TILS UTILIZING AKT PATHWAYS INHIBITORS | 2022-02-03 |
20220033776 | METHODS OF MAKING PLATELETS COMPRISING MODIFIED RECEPTORS AND USES THEREOF | 2022-02-03 |
20220033777 | TARGET-PRIMED MACROPHAGES AND THERAPEUTIC USES THEREOF | 2022-02-03 |
20220033778 | METHODS FOR EX VIVO EXPANSION OF NATURAL KILLER CELLS AND USE THEREOF | 2022-02-03 |
20220033779 | GENETICALLY MODIFIED MESENCHYMAL STEM CELL EXPRESSING KLOTHO | 2022-02-03 |
20220033780 | METHOD FOR PREPARING INTESTINAL ORGANOID DERIVED FROM PLURIPOTENT STEM CELL | 2022-02-03 |
20220033781 | ARTIFICIAL RECOMBINANT CHROMOSOME AND USE THEREOF | 2022-02-03 |
20220033782 | ADENOVIRUS-ASSOCIATED VIRUSES SEPARATION METHOD | 2022-02-03 |
20220033783 | METHODS AND COMPOSITIONS FOR TREATING NEGATIVE-SENSE SINGLE-STRANDED RNA VIRUS | 2022-02-03 |
20220033784 | RECOMBINANT VACCINIA VIRUS | 2022-02-03 |
20220033785 | RNA PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND USES THEREOF | 2022-02-03 |
20220033786 | PROVISION OF MALONYL-COA IN CORYNEFORM BACTERIA AND METHOD FOR PRODUCING POLYPHENOLES AND POLYKETIDES WITH CORYNEFORM BACTERIA | 2022-02-03 |
20220033787 | COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY | 2022-02-03 |
20220033788 | RECOMBINANT COMPONENTS AND COMPOSITIONS FOR USE IN FOOD PRODUCTS | 2022-02-03 |
20220033789 | GDSL LIPASE, GENETICALLY-ENGINEERED BACTERIA AND APPLICATION THEREOF | 2022-02-03 |
20220033790 | MICROORGANISM FOR PRODUCING DICARBOXYLIC ACID, AND METHOD FOR PRODUCING DICARBOXYLIC ACID USING SAME | 2022-02-03 |
20220033791 | ENZYMES WITH RUVC DOMAINS | 2022-02-03 |
20220033792 | METHODS AND COMPOSITIONS FOR CELLULAR REPROGRAMMING | 2022-02-03 |
20220033793 | NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS | 2022-02-03 |
20220033794 | ACTIVE LOW MOLECULAR WEIGHT VARIANTS OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) | 2022-02-03 |
20220033795 | COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN | 2022-02-03 |
20220033796 | PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN | 2022-02-03 |
20220033797 | NOVEL HALOPHILIC BACILLUS AMYLOLIQUEFACIENS KMUS1 WHICH PRODUCES THROMBOLYTIC ENZYME NATTOKINASE | 2022-02-03 |
20220033798 | USE AND PRODUCTION OF STORAGE-STABLE NEUTRAL METALLOPROTEASE | 2022-02-03 |
20220033799 | Polypeptides having Peptidoglycan Degrading Activity and Polynucleotides Encoding Same | 2022-02-03 |
20220033800 | ENGINEERED BIOSYNTHETIC PATHWAYS FOR PRODUCTION OF 1,5-DIAMINOPENTANE BY FERMENTATION | 2022-02-03 |
20220033801 | COMPOSITIONS AND METHODS FOR NON-ANTIBIOTIC TREATING OF BACTERIAL INFECTIONS BY BLOCKING OR DISRUPTING BACTERIAL GENES INVOLVED IN VIRULENCE OR VIABILITY | 2022-02-03 |
20220033802 | METHOD AND APPARATUS FOR ENCODING CELLULAR SPATIAL POSITION INFORMATION | 2022-02-03 |
20220033803 | METHOD OF EXTRACTING MIRNA AND METHOD OF ANALYZING MIRNA | 2022-02-03 |
20220033804 | Methods and Compositions for Enhancement of Stem Cell-based Immunomodulation and Tissue Repair | 2022-02-03 |
20220033805 | HIGH-THROUGHPUT SINGLE-NUCLEI AND SINGLE-CELL LIBRARIES AND METHODS OF MAKING AND OF USING | 2022-02-03 |
20220033806 | System and Method for Modular and Combinatorial Nucleic Acid Sample Preparation for Sequencing | 2022-02-03 |
20220033807 | METHOD FOR CAPTURING RNA IN SITU HIGHER-ORDER STRUCTURES AND INTERACTIONS | 2022-02-03 |
20220033808 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID-GUIDED NUCLEASE CELL TARGETING SCREEN | 2022-02-03 |
20220033809 | METHOD AND KIT FOR CONSTRUCTION OF RNA LIBRARY | 2022-02-03 |
20220033810 | SINGLE CELL ASSAY FOR TRANSPOSASE-ACCESSIBLE CHROMATIN | 2022-02-03 |
20220033811 | METHOD AND KIT FOR PREPARING COMPLEMENTARY DNA | 2022-02-03 |
20220033812 | SURFACE EXPRESSION VECTOR FOR CONSTITUTIVE HIGH-EXPRESSION USING PROMOTER OF GALACTOSE MUTAROTASE GENE DERIVED FROM LACTOBACILLUS CASEI, AND USE THEREOF | 2022-02-03 |
20220033813 | L-OLIGONUCLEOTIDE INHIBITORS OF POLYCOMB REPRESSIVE COMPLEX 2 (PRC2) | 2022-02-03 |
20220033814 | METHODS FOR THE TREATMENT OF TRINUCLEOTIDE REPEAT EXPANSION DISORDERS ASSOCIATED WITH MLH1 ACTIVITY | 2022-02-03 |
20220033815 | SYSTEMIC IN VIVO DELIVERY OF OLIGONUCLEOTIDES | 2022-02-03 |
20220033816 | USE OF miRNA 148 CLUSTER AS MARKER FOR DIAGNOSING AND/OR TREATING COGNITIVE IMPAIRMENT-ASSOCIATED DISEASES | 2022-02-03 |
20220033817 | Targeting Ligands | 2022-02-03 |
20220033818 | OLIGONUCLEOTIDES TARGETING RNA BINDING PROTEIN SITES | 2022-02-03 |
20220033819 | COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIAC DISEASES | 2022-02-03 |
20220033820 | COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY | 2022-02-03 |
20220033821 | SHORT DNA APTAMERS AND METHODS FOR PROMOTING REMYELINATION | 2022-02-03 |
20220033822 | Expression of miRNAs in Placental Tissue | 2022-02-03 |
20220033823 | RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITING EXPRESSION OF DYSTROPHIA MYOTONICA PROTEIN KINASE AND/OR INTERFERING WITH A TRINUCLEOTIDE REPEAT EXPANSION IN THE 3' UNTRANSLATED REGION OF THE DMPK GENE | 2022-02-03 |
20220033824 | MODULATION OF SPTLC1 VIA RECOMBINANT ADENO-ASSOCIATED VECTORS | 2022-02-03 |
20220033825 | POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF | 2022-02-03 |
20220033826 | ADENO-ASSOCIATED VIRAL VECTORS FOR THE TREATMENT OF BEST DISEASE | 2022-02-03 |
20220033827 | Baicalein- and Scutellarein- Synthesizing Microorganism, Preparation Method and Applications Thereof | 2022-02-03 |
20220033828 | GENETICALLY ENGINEERED CYANOBACTERIA FOR GROWTH IN UNSTERILIZED CONDITIONS USING ANTIBIOTIC-FREE SELECTION | 2022-02-03 |
20220033829 | PEPTIDE BARCODES FOR CORRELATING NUCLEIC ACID-GUIDED NUCLEASE OR NICKASE FUSION EDITING AND PROTEIN TRANSLATION IN A POPULATION OF CELLS | 2022-02-03 |
20220033830 | FUNCTIONALIZATION OF ENDOGENOUS BACTERIA | 2022-02-03 |
20220033831 | SYSTEMS AND METHODS FOR HIGH-THROUGHPUT AUTOMATED STRAIN GENERATION FOR NON-SPORULATING FUNGI | 2022-02-03 |
20220033832 | MODIFIED AOX1 PROMOTER VARIANTS | 2022-02-03 |
20220033833 | COMPOSITIONS AND METHODS FOR TRANSFERRING BIOMOLECULES TO WOUNDED CELLS | 2022-02-03 |
20220033834 | INHT31 TRANSGENIC SOYBEAN | 2022-02-03 |
20220033835 | RICE PLANT MATERIAL RESISTANT AGAINST BIOTIC STRESS | 2022-02-03 |
20220033836 | INIR12 TRANSGENIC MAIZE | 2022-02-03 |
20220033837 | METHODS AND MEANS FOR MODIFYING THE ALKALOID CONTENT OF PLANTS | 2022-02-03 |
20220033838 | BRASSICA EVENT MON94100 AND METHODS OF USE THEREOF | 2022-02-03 |
20220033839 | METHODS AND COMPOSITIONS FOR PPO HERBICIDE TOLERANCE | 2022-02-03 |
20220033840 | SOLANACEOUS PLANT RESISTANT TO VIRUS OF GENUS BEGOMOVIRUS CAUSING TOMATO YELLOW LEAF CURL SYMPTOMS, SOLANACEOUS PLANT CELL, AND METHOD FOR PRODUCING SOLANACEOUS PLANT | 2022-02-03 |
20220033841 | DISCOVERY OF SOYBEAN CYST NEMATODE RESISTANCE GENES BASED ON EPIGENETIC ANALYSIS | 2022-02-03 |
20220033842 | INIR12 TRANSGENIC MAIZE | 2022-02-03 |
20220033843 | ENHANCING THE EFFECTIVENESS OF BLENDED REFUGE | 2022-02-03 |
20220033844 | CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF | 2022-02-03 |
20220033845 | EXPRESSION VECTORS FOR EUKARYOTIC EXPRESSION SYSTEMS | 2022-02-03 |
20220033846 | APP MODIFICATION VIA BASE EDITING USING THE CRISPR/CAS9 SYSTEM | 2022-02-03 |
20220033847 | NON-HUMAN ANIMALS EXPRESSING HUMANIZED C1Q COMPLEX | 2022-02-03 |
20220033848 | A MODULAR, POLYCISTRONIC VECTOR FOR CAR AND TCR TRANSDUCTION | 2022-02-03 |
20220033849 | METHODS FOR THE PURIFICATION OF VIRAL VECTORS | 2022-02-03 |
20220033850 | DESIGN OF BACTERIOPHAGE-BASED ARTIFICIAL VIRUSES FOR HUMAN GENOME REMODELING | 2022-02-03 |
20220033851 | mRNA, episomal and genomic integrated lentiviral and gammaretroviral vector expression of dimeric immunoglobulin A and polymeric immunoglobulin A to Enable Mucosal and Hematological Based Immunity/Protection via Gene Therapy for Allergens, viruses, HIV, bacteria, pneumonia, infections, pathology associated proteins, systemic pathologies, cancer, toxins and unnatural viruses. CAR engineered and non-CAR engineered immune cell expression of dimeric immunoglobulin A and polymeric immunoglobulin A. | 2022-02-03 |
20220033852 | RNA Replicon for Versatile and Efficient Gene Expression | 2022-02-03 |
20220033853 | GENE TRANSFECTION SYSTEM AND METHOD | 2022-02-03 |
20220033854 | SYSTEMS AND METHODS FOR EXPRESSING PROTEINS | 2022-02-03 |
20220033855 | ARRAYED NUCLEIC ACID-GUIDED NUCLEASE OR NICKASE FUSION EDITING | 2022-02-03 |
20220033856 | METHODS FOR INCREASING FETAL HEMOGLOBIN CONTENT IN EUKARYOTIC CELLS AND USES THEREOF FOR THE TREATMENT OF HEMOGLOBINOPATHIES | 2022-02-03 |
20220033857 | EDITING OF HAEMOGLOBIN GENES | 2022-02-03 |
20220033858 | CRISPR OLIGONCLEOTIDES AND GENE EDITING | 2022-02-03 |
20220033859 | INCREASED BIOACTIVITY OF BIOPROTECTIVE CULTURES AGAINST PATHOGENIC BACTERIA | 2022-02-03 |
20220033860 | METHOD FOR CARRING OUT THE COMBINED OPERATION OF A BIOETHANOL PRODUCTION UNIT AND A BIOGAS UNIT | 2022-02-03 |
20220033861 | SOLUBILIZATION OF MSW WITH BLEND ENZYMES | 2022-02-03 |